Utpal Koppikar - Jul 9, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Director
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
Jul 9, 2021
Transactions value $
$0
Form type
4
Date filed
7/12/2021, 04:06 PM
Previous filing
Jun 9, 2021
Next filing
Aug 19, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLXN Stock option (right to buy) Award $0 +32K $0.00 32K Jul 9, 2021 Common Stock 32K $7.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option will vest on July 9, 2022, and the balance of the shares will vest in a series of 24 equal monthly installments thereafter.